BPA - Agilent
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new Blanket Purchase Agreement (BPA) requirement for Agilent analytical laboratory instruments, specifically Ultra High-Performance Liquid Chromatography (UHPLC) and Gas Chromatography Triple Quadrupole (GC QQQ) equipment for chemistry analysis applications. The solicitation is estimated to be released on December 1, 2025, with an anticipated award date of May 1, 2026. This procurement falls under the Analytical Laboratory Instrument Manufacturing NAICS category and does not utilize any set-aside provisions.
The estimated contract award value ranges from $250,000 to $700,000. The FDA's Acquisition Liaison mailbox (hfpacquisitions@fda.hhs.gov) serves as the primary point of contact for inquiries regarding this opportunity. Interested vendors should monitor the forecasted solicitation release date and prepare technical proposals demonstrating their capability to provide the specified analytical instrumentation for the FDA's chemistry analysis requirements.
Forecast text
BPA - Agilent
Various UHPLC, GC QQQ for use in chemistry analysis.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast